WEEDING OUT THE ASX'S BURGEONING CANNABIS TREND: 8 COMPANIES TO WATCH
5 April 2017, Written by Paris Faint
A NICHE is budding on the ASX in the form of medical cannabis, an industry which has been on the country's radar over the past six months.
Recent legislative changes have allowed for importation of the drug and patient-specific sales, as government red tape and other legal barriers are being systematically lifted.
The Narcotic Drugs Amendment Bill passed through both houses of Parliament last year allows for production of processed non-herbal and non-smokeable medicinal grade products, to be used by eligible patients including severe epileptics and cancer sufferers.
Following this legislative change and others, there are now several publicly listed companies in Australia that are gaining grass-roots attention by capitalising on cannabis production, import and sale.
Business News Australia has compiled a list of stocks to watch, as analysts indicate the trend will amount to more than just pot-luck on the ASX.
ZELDA THERAPEUTICS (ASX: ZLD)